Decision-making in investment in overseas R&D

被引:1
|
作者
O'Malley, Chris [1 ]
机构
[1] Univ Wales, Newport, Gwent, Wales
基金
爱尔兰科学基金会;
关键词
business & management studies; technology & innovation studies; qualitative R&D management; biotechnology; information and communications technology; STRATEGIC MANAGEMENT; ENTRY MODE; INTERNATIONALIZATION; LOCATION;
D O I
10.1080/09537325.2012.705121
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
According to the literature, multinational firms are motivated to locate R&D activity overseas for mainly three reasons, namely: to adapt to local markets; access lower cost R&D capacity; or access unique research capability. Ireland at the beginning of the century appeared, from this finding, badly placed to attract R&D in foreign direct investment (FDI), as it had by global comparisons neither a large domestic market, a low cost economy nor a strong R&D profile. In spite of this, Ireland has succeeded in attracting significant investment in R&D projects. The cases of investment in Ireland analysed here reveal that the nature of the decision-making process itself has been a decisive factor in the outcome, and that less quantifiable factors such as cultural closeness, history, and personal relationships have played a stronger role in the outcome than would be expected from the literature.
引用
收藏
页码:697 / 709
页数:13
相关论文
共 50 条
  • [1] Using game theory to model R&D investment decision-making under uncertainty
    Sun, Yan-Mei
    Sun, Chang-Xiong
    [J]. Harbin Gongcheng Daxue Xuebao/Journal of Harbin Engineering University, 2010, 31 (08): : 1115 - 1122
  • [2] 'Big data' patentometrics for R&D decision-making
    Verma, Charu
    Suri, Pradeep Kumar
    [J]. DIGITAL POLICY REGULATION AND GOVERNANCE, 2021, 23 (04) : 317 - 336
  • [3] Mitigating bias in pharmaceutical R&D decision-making
    Truebel, Hubert
    Seidler, Mark
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (12) : 874 - 875
  • [4] Mitigating bias in pharmaceutical R&D decision-making
    Hubert Truebel
    Mark Seidler
    [J]. Nature Reviews Drug Discovery, 2022, 21 : 874 - 875
  • [5] Corporate decision-making in R&D outsourcing and the impact on internal R&D employment intensity
    Teirlinck, Peter
    Dumont, Michel
    Spithoven, Andre
    [J]. INDUSTRIAL AND CORPORATE CHANGE, 2010, 19 (06) : 1741 - 1768
  • [6] More clinical input required for R&D decision-making?
    Jain, KK
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (04) : 175 - 176
  • [7] Data-Driven Decision-Making in Product R&D
    Fabijan, Aleksander
    Olsson, Helena Holmstrom
    Bosch, Jan
    [J]. AGILE PROCESSES, IN SOFTWARE ENGINEERING, AND EXTREME PROGRAMMING, XP 2015, 2015, 212 : 350 - 351
  • [8] Mental model approach applied to R&D decision-making
    Vislosky, D.M.
    Fischbeck, P.S.
    [J]. International Journal of Technology Management, 2000, 19 (03) : 453 - 471
  • [9] Game analysis on the decision-making procedure of R&D cooperation
    Zhang, Y
    Zhang, ZG
    Huang, SJ
    Zhu, YJ
    [J]. PROCEEDINGS OF 2002 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE & ENGINEERING, VOLS I AND II, 2002, : 2043 - 2049
  • [10] A Decision-making Approach to R&D Project in a Fuzzy Environment
    Yi, Changsheng
    Ning, Yufu
    Jin, Qiumei
    [J]. 2008 ISECS INTERNATIONAL COLLOQUIUM ON COMPUTING, COMMUNICATION, CONTROL, AND MANAGEMENT, VOL 2, PROCEEDINGS, 2008, : 90 - +